Literature DB >> 12548165

Effect of time interval on residual disease in breast cancer.

Elizabeth L Wiley1, Leslie K Diaz, Sunil Badve, Monica Morrow.   

Abstract

The histologic responses of breast tissue to injury are limited. Needle core biopsies of the breast are associated with displacement of tumor cells, and the incidence of tumor displacement decreases as the time interval between needle core biopsy and subsequent excision increases. This suggests that displaced tumor cells are destroyed by reparative processes induced by tissue injury. Residual tumor in a lumpectomy site may also be subjected to the same destructive processes associated with tissue repair. A total of 259 consecutive cases of infiltrating ductal carcinoma with margin-positive lumpectomies and their associated reexcision specimens obtained over a 7-year period were analyzed for the presence, type, and quantity of residual disease. The overall incidence of residual disease was 69%. Residual infiltrating ductal carcinoma was present in 35% of cases, and residual ductal carcinoma in situ was present in 50%. An increased time interval between lumpectomy and reexcision was associated with a decreased incidence of residual infiltrating carcinoma (p <0.0043); this decrease was not found associated with ductal carcinoma in situ. These findings suggest that the host response to injury may destroy residual infiltrating carcinoma cells in some margin-positive cases.

Entities:  

Mesh:

Year:  2003        PMID: 12548165     DOI: 10.1097/00000478-200302000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Comparison of mammography and ultrasound in detecting residual disease following bioptic lumpectomy in breast cancer patients.

Authors:  Xiufeng Wu; Qingzhong Lin; Jianping Lu; Gang Chen; Y I Zeng; Yinglan Lin; Ying Chen; Yaoqin Wang; Jun Yan
Journal:  Mol Clin Oncol       Date:  2016-01-14

2.  What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates.

Authors:  Michelle Azu; Paul Abrahamse; Steven J Katz; Reshma Jagsi; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

3.  Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer.

Authors:  Alison Unzeitig; Anne Kobbermann; Xian-Jin Xie; Jingsheng Yan; David Euhus; Yan Peng; Venetia Sarode; Amy Moldrem; A Marilyn Leitch; Valerie Andrews; Roshni Rao
Journal:  Int J Surg Oncol       Date:  2012-01-16

4.  A Raman Imaging Approach Using CD47 Antibody-Labeled SERS Nanoparticles for Identifying Breast Cancer and Its Potential to Guide Surgical Resection.

Authors:  Ryan M Davis; Jos L Campbell; Sean Burkitt; Zhen Qiu; Soyoung Kang; Mana Mehraein; Dominie Miyasato; Helen Salinas; Jonathan T C Liu; Cristina Zavaleta
Journal:  Nanomaterials (Basel)       Date:  2018-11-20       Impact factor: 5.076

5.  Evaluation of resection margins in breast conservation therapy: the pathology perspective-past, present, and future.

Authors:  Rajyasree Emmadi; Elizabeth L Wiley
Journal:  Int J Surg Oncol       Date:  2012-11-19

6.  Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance.

Authors:  W B G Sanderink; L J A Strobbe; P Bult; M S Schlooz-Vries; S Lardenoije; D J Venderink; I Sechopoulos; N Karssemeijer; W Vreuls; R M Mann
Journal:  Breast Cancer Res Treat       Date:  2020-08-01       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.